Yun Ho Bio

BiotechnologySeries ASuzhou, China

Latest round

Series A

Last raised

Aug 2025

Total raised

Undisclosed

Investors

1

About Yun Ho Bio

, dba Yun Ho Bio, is a biopharmaceutical company primarily engaged in the research and development of small nucleic acid drugs with a focus on AI (Artificial Intelligence)-driven RNAi innovative therapy development. Yun Ho Bio mainly engages in AI-assisted extrahepatic siRNA drug development, medical research and experimental development, and biopharmaceutical R&D. The company has established an AI-assisted end-to-end small nucleic acid drug development platform, a multi-organ targeted delivery system, and a chemical modification platform, enabling cost reduction and efficiency improvement in drug development. Yun Ho Bio primarily generates revenue through biopharmaceutical R&D combined with comprehensive technical services related to medical technology.

Who invested in Yun Ho Bio

1 investor across 1 round

See all investors in Yun Ho Bio

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Aug 6, 2025

    Amount

    Undisclosed

    Investors

    Locked

Questions about Yun Ho Bio

Who invested in Yun Ho Bio?

Yun Ho Bio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Yun Ho Bio raised?

Yun Ho Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Yun Ho Bio last raise money?

Yun Ho Bio's most recent round on record is a Series A, in Aug 2025.

What does Yun Ho Bio do?

, dba Yun Ho Bio, is a biopharmaceutical company primarily engaged in the research and development of small nucleic acid drugs with a focus on AI (Artificial Intelligence)-driven RNAi innovative therapy development.

Where is Yun Ho Bio headquartered?

Yun Ho Bio is headquartered in Suzhou, China.

Which VCs invest in companies like Yun Ho Bio?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Yun Ho Bio's stage. Their profiles are linked below.

Raising like Yun Ho Bio? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.